NDC 66658-522 – Gamifant
Emapalumab 50 mg/2mL · Injection · Intravenous
Product NDC66658-522
Product details
- Brand name
- Gamifant
- Generic name
- Emapalumab-lzsg
- Labeler
- Swedish Orphan Biovitrum AB (publ)
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761107
- Marketed since
- June 7, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interferon gamma Blocker
Active ingredients
- Emapalumab 50 mg/2mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 66658-522-01 | 1 VIAL, SINGLE-USE in 1 CARTON (66658-522-01) / 2 mL in 1 VIAL, SINGLE-USE | Jun 7, 2023 |
Other Gamifant products
- 66658-501 Emapalumab 10 mg/2mL · Injection · Swedish Orphan Biovitrum AB (publ)
- 66658-505 Emapalumab 50 mg/10mL · Injection · Swedish Orphan Biovitrum AB (publ)
- 66658-510 Emapalumab 100 mg/20mL · Injection · Swedish Orphan Biovitrum AB (publ)
- 66658-523 Emapalumab 100 mg/4mL · Injection · Swedish Orphan Biovitrum AB (publ)
- 66658-524 Emapalumab 250 mg/10mL · Injection · Swedish Orphan Biovitrum AB (publ)
- 66658-525 Emapalumab 500 mg/20mL · Injection · Swedish Orphan Biovitrum AB (publ)